44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Molecular Cancer

Sign up for email alert when new content gets added: Sign up

Case report: Use of angioseal to close entry point of Central Venous Cathete (CVC) into subclavian artery 6 days after mistaken insertion

Joint Event on World Congress on Breast Cancer & 5th International Conference on Vascular Biology & Surgeons Meeting

February 25-26, 2019 London, UK

Ori Eyal

Rambam Medical Centre, Israel

Keynote: J Molecular Cancer

Abstract :

Ultrasound guided CVC insertion was performed in the hematological oncological ward in a acute myeloid leukemic patient, thrombocytopenic 20,000, with chronic renal failure and immune system failure in a septic shock state. The CVC was inserted into the right subclavien artery. Due to the fragile state of this patient the CVC was left in place [arterial line] for 6 days until his platelet count was elevated and his shock state overcome with antibiotics. The interventional Radiologist removed the CVC with the use of angioseal device. This case demonstrates that a CVC may be left in place as an arterial line for a number of days until the patient is stabilized and able to undergo an interventional procedure.

Biography :

Ori Eyal graduated from Debrecen, Hungry Medical school in 2009. He is currently working in Rambam Medical Centre Haifa Israel as a vascular and transplant Surgery Resident. FLS certified. He is a winner of 2 consecutive laparoscopy simulator Israeli residency competitions. His research interest is about all-round surgeon in general and vascular surgery. He is Currently working as a vascular and transplant surgery resident in hospital and as a general surgeon consultant.

E-mail: oriscoby@hotmail.com

 
Google Scholar citation report
Citations : 6

Journal of Molecular Cancer received 6 citations as per Google Scholar report

Journal of Molecular Cancer peer review process verified at publons
pulsus-health-tech
Top